Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation.
about
Metformin counters the insulin-induced suppression of fatty acid oxidation and stimulation of triacylglycerol storage in rodent skeletal muscleRegulation of AMP-activated protein kinase by a pseudosubstrate sequence on the gamma subunitAdiponectin lowers glucose production by increasing SOGAC1q/TNF-related protein-3 (CTRP3), a novel adipokine that regulates hepatic glucose outputThe adiponectin paralog CORS-26 has anti-inflammatory properties and is produced by human monocytic cellsT-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectinUp- and down-regulation of adiponectin expression and multimerization: mechanisms and therapeutic implicationImpact of increased adipose tissue mass on inflammation, insulin resistance, and dyslipidemiaUpregulation of mitochondrial uncoupling protein-2 by the AMP-activated protein kinase in endothelial cells attenuates oxidative stress in diabetesAssociation between lifestyle factors and plasma adiponectin levels in Japanese men.Adiponectin: a versatile player of innate immunityAdiponectin signaling and function in insulin target tissuesPerspective of Small-Molecule AdipoR Agonist for Type 2 Diabetes and Short Life in ObesityAdiponectin serum level in chronic hepatitis C infection and therapeutic profileAdiponectin, driver or passenger on the road to insulin sensitivity?Differential Role of Leptin and Adiponectin in Cardiovascular SystemAMPK: a cellular metabolic and redox sensor. A minireviewAdipocytokines and obesity-linked disordersObesity is associated with macrophage accumulation in adipose tissueMetabolic Adaptation in Obesity and Type II Diabetes: Myokines, Adipokines and HepatokinesAdipose tissue dysfunction and its effects on tumor metabolismInhibition of inducible nitric-oxide synthase by activators of AMP-activated protein kinase: a new mechanism of action of insulin-sensitizing drugsEpoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null miceRecombinant adiponectin does not lower plasma glucose in animal models of type 2 diabetesA highly conserved tryptophan in the N-terminal variable domain regulates disulfide bond formation and oligomeric assembly of adiponectinMolecular, biochemical and functional characterizations of C1q/TNF family members: adipose-tissue-selective expression patterns, regulation by PPAR-gamma agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functionsActivation of AMP-activated protein kinase signaling pathway by adiponectin and insulin in mouse adipocytes: requirement of acyl-CoA synthetases FATP1 and Acsl1 and association with an elevation in AMP/ATP ratioA family of Acrp30/adiponectin structural and functional paralogsAdiponectin enhances intercellular adhesion molecule-1 expression and promotes monocyte adhesion in human synovial fibroblastsCentral inflammation and leptin resistance are attenuated by ginsenoside Rb1 treatment in obese mice fed a high-fat dietIdentification of Putative Receptors for the Novel Adipokine CTRP3 Using Ligand-Receptor Capture TechnologyOligomerization and regulated proteolytic processing of angiopoietin-like protein 4Undernutrition during suckling in rats elevates plasma adiponectin and its receptor in skeletal muscle regardless of diet composition: a protective effect?The oligomeric structure of high molecular weight adiponectinC1q/TNF-related protein-12 (CTRP12), a novel adipokine that improves insulin sensitivity and glycemic control in mouse models of obesity and diabetesAdiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndromeAdipokines in inflammation and metabolic diseaseAdiponectin and cardiovascular disease: state of the art?Prenatal androgenization of female mice programs an increase in firing activity of gonadotropin-releasing hormone (GnRH) neurons that is reversed by metformin treatment in adulthoodThe helix-loop-helix factors Id3 and E47 are novel regulators of adiponectin.
P2860
Q22241966-86A8CF00-2A94-4E3E-9EF4-94365953CFDFQ24294651-13465E31-67F1-4EB2-9FA6-9ED0E06CAAB9Q24298469-4DFFAB7D-B295-4702-8A2F-A0E8232D68E0Q24303598-488042B2-8C52-4393-88A2-6325D05082D9Q24337848-68606A3B-D640-4B90-850A-0A57F1AE071EQ24564272-6522C14A-1E4D-4D13-A474-738B6CDA0A3CQ24633408-3FA762C9-E2F0-420A-9EBD-BF2192507957Q24645182-E83983BF-AA8F-493E-B435-DF93D01D987CQ24656627-CF3E43F2-C0E4-4C0E-B35F-4F56B423B058Q24812059-8C70113E-58E1-4526-A834-7B818A63597FQ26753340-A5BD7CDC-65ED-473A-9489-4A1814719136Q26753354-2EF0A12F-293B-4EDC-B137-F9F35CD8A457Q26777180-FE20EF2F-74EF-4391-9B58-404DE303E4C0Q26827639-49FD8EAE-960B-4638-B048-56D025F6CC5BQ26827971-9FAF96AF-49F7-491E-8DDC-F88C816E7020Q26864590-8ECA96FF-A234-407A-AECE-490F4721B9E9Q26995682-6F47CF8C-5C04-4806-A0F2-F1CC08C704E2Q27021977-18CBFEC5-3546-40A0-8ED3-D54498046B26Q27860976-18272828-FE40-4680-A006-AB6FE287E352Q28066564-E7642854-6542-44BD-8472-25A4D5F144A9Q28080748-0C6832BA-FB45-4B9C-B5A7-591C91FA085EQ28246959-AEFF1B3E-87E7-416C-B087-5A97FD3201CBQ28392299-78F8F7AD-5927-4FE7-AD61-A9D277DED256Q28484170-AA2EF1AA-58F0-4BCC-B46D-76C5F0AF9C6BQ28508158-783DFC66-6B07-47FB-86B9-1835124C31C2Q28508387-DC1024FD-7AA1-4688-AC21-6EAB69475AB7Q28509384-A9196394-D6D4-4041-BEF4-33DF6262A883Q28513966-04C76A8D-1252-4E48-8623-C77779D3B8ABQ28541499-08EF3C25-422B-402B-B58E-46632493F6F0Q28541621-43EBCB37-A556-4048-B85B-8DDA8B73C9F7Q28554627-2A5B2BCE-F1E9-43B0-A7D5-DD44D6DA6056Q28565894-21E1E9F2-7B68-4864-B1E6-B7D1051BFCC5Q28566924-F4BEEA08-F834-4978-A59F-6181E18C7C7FQ28587638-A27A9F1E-0883-4406-A530-9B5F5906B012Q28591360-8C1683D8-2A8F-413A-942A-C25AF7844075Q29619211-105A483F-27A5-4210-95B1-A45575BEA222Q29620456-7C8015CE-CA7B-48DD-B505-89B8797558ABQ30358456-5088EEB1-1FCD-4650-AC67-4CAE658F9465Q30428511-618EE2E0-DCE8-46A3-A66A-933FF2B29F91Q30438518-5ADE56A8-E4BC-45B7-9BB9-2942AFBB6587
P2860
Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Enhanced muscle fat oxidation ...... ted protein kinase activation.
@ast
Enhanced muscle fat oxidation ...... ted protein kinase activation.
@en
Enhanced muscle fat oxidation ...... ted protein kinase activation.
@nl
type
label
Enhanced muscle fat oxidation ...... ted protein kinase activation.
@ast
Enhanced muscle fat oxidation ...... ted protein kinase activation.
@en
Enhanced muscle fat oxidation ...... ted protein kinase activation.
@nl
prefLabel
Enhanced muscle fat oxidation ...... ted protein kinase activation.
@ast
Enhanced muscle fat oxidation ...... ted protein kinase activation.
@en
Enhanced muscle fat oxidation ...... ted protein kinase activation.
@nl
P2093
P2860
P50
P356
P1476
Enhanced muscle fat oxidation ...... ted protein kinase activation.
@en
P2093
Cheng cheng Zhang Cc
Heather E Murrey
Samar I Itani
Tsu-Shuen Tsao
P2860
P304
16309-16313
P356
10.1073/PNAS.222657499
P407
P577
2002-11-27T00:00:00Z